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Brief Communications
In Vivo Imaging Reveals Dissociation between Caspase
Activation and Acute Neuronal Death in Tangle-Bearing
Neurons
Tara L. Spires-Jones,1 Alix de Calignon,1 Toshifumi Matsui,1 Cindy Zehr,3 Rose Pitstick,4Hai-YanWu,1
Jennifer D. Osetek,1 Phillip B. Jones,1,2 Brian J. Bacskai,1Mel B. Feany,5 George A. Carlson,4 Karen H. Ashe,6 Jada Lewis,3
Bradley T. Hyman1
1MassGeneral Institute for Neurodegenerative Disease and 2Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Harvard Medical
School, Charlestown, Massachusetts 02129, 3Neurogenetics, Neurotransgenics and Neuropathology Laboratories, Mayo Clinic, Jacksonville, Florida 32224,
4McLaughlin Research Institute, Great Falls, Montana 59405, 5Department of Pathology, Brigham andWomen’s Hospital and Harvard Medical School,
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Accumulationof neurofibrillary tangles (NFTs) inAlzheimer’s disease correlateswithneuronal loss and cognitive decline, but theprecise
relationship between NFTs and neuronal death and downstream mechanisms of cell death remain unclear. Caspase cleaved products
accumulate in tangles, implying that tanglesmay contribute to apoptotic neuronal death. To test this hypothesis, we developedmethods
using multiphoton imaging to detect both neurofibrillary pathology and caspase activation in the living mouse brain. We examined
rTg4510mice, a reversiblemousemodel of tauopathy that develops tangles andneuronal loss. Only a small percentage of imagedneurons
were caspase activity positive, but the vast majority of the cells with active caspases contained NFTs. We next tested the hypothesis that
caspase activation led to acute, apoptotic neuronal death. Caspase positive cell bodies did not degenerate over hours of imaging, despite
the presence of activated executioner caspases. Suppression of the transgene, which stops ongoing death, did not suppress caspase
activity. Finally, histochemical assessments revealed evidence of caspase-cleaved tau, but no TUNEL (terminal deoxynucleotidyl
transferase-mediated biotinylated UTP nick end labeling) positive or apoptotic nuclei. With the novel technique of observing NFTs and
caspase activation in the living brain, we demonstrate that aggregated tau in neurons can be associated with caspase activation, but that
caspase activation is not sufficient to cause acute neuronal death in this model.
Key words: Alzheimer’s; neurofibrillary tangle; caspase; apoptosis; multiphoton imaging; tauopathy
Introduction
Conventional histological studies of human Alzheimer’s disease
(AD) and animal models of tauopathies have shown that certain
neuronal populations appear to be vulnerable to both neurofi-
brillary tangle (NFT) formation and neuronal loss (Terry et al.,
1981; Arriagada et al., 1992; Lewis et al., 2000; Zehr et al., 2004;
Andorfer et al., 2005; Spires et al., 2006) and that neuronal loss
outstrips tangle number by orders of magnitude (Gomez-Isla et
al., 1997; Spires et al., 2006). These observations give rise to two
possible scenarios: vulnerable neurons develop a tangle which
eventually causes the cell to die, then the tangle is cleared; or
vulnerable neurons either die or develop a tangle. If the latter is
the case, tangles could be viewed, paradoxically, as protective or
neutral.
Evidence for both possibilities exist although the idea that
tangles are toxic has been regarded as most likely. In histologic
studies, NFTs are associated with immunohistochemical evi-
dence of caspase activation and caspase-cleavage products,
leading to the hypothesis that NFTs cause apoptotic death
(Gamblin et al., 2003; Rissman et al., 2004). However, some
data from cell culture experiments, mouse models, and disease
caused by tau mutations that causes cell death but not tangle
formation indicate that protein inclusionsmay be unnecessary
for neuronal death or even protect cells from toxic soluble
moieties (Saudou et al., 1998; Reed et al., 2001; Bodner et al.,
2006; Spires et al., 2006).
Determining the relationship between NFTs and neuronal
death is critical for development of appropriate therapeutic strat-
egies, but analysis has been hampered by limitations of cross-
sectional studies to discern the fate of tangle-bearing or non-
tangle-bearing neurons. We therefore developed a method to
image NFTs and caspase activation in the intact brain. We find
that a small minority of neurons are caspase positive and that the
vast majority of caspase positive neurons contain a tangle. If
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caspase activation led to acute apoptotic cell death, we would
expect rapid degeneration of caspase containing neurons. In-
stead, we observed that neuronal cell bodies with activated
caspases do not degenerate over the course of hours in vivo, and
markers for the end stages of apoptosis were absent. Further-
more, caspase activity continued after suppressing the tau trans-
gene, despite cessation of neuronal death, again demonstrating dis-
sociation between caspase activation and acute neuronal death.
Materials andMethods
Surgery and imaging. Animal experiments were performed under na-
tional and institutional guidelines. We used rTg4510 mice aged 5–10
months (n  28), which reversibly express P301L mutant human tau
(SantaCruz et al., 2005). Age-matched littermates expressing only the
activator transgene were used as negative controls (n  20). A craniot-
omy was performed as described previously (Skoch et al., 2004). Before a
glass coverslip was sealed over the craniotomy, dura were resected from
the cortical surface and a PBS solution containing Thioflavin S (0.01,
0.025, 0.1, or 0.2% ThioS; Sigma, St. Louis, MO) and a fluorescent indi-
cator of caspase activation (FLICA indicators, five times concentration,
polycaspase indicator, caspase 3 plus 7 indicator, or caspase 8 indicator;
Invitrogen, Eugene OR) was applied for 20 min. Two animals were
treatedwith topical application of z-vad-fmkpan-caspase inhibitor (Pro-
mega, Madison, WI; 50 M in PBS) for 30 min before application of
polycaspase indicator and ThioS. After initial imaging, the caspase inhib-
itor was washed out and the caspase indicator and ThioS solution reap-
plied. A subset of animals (n  3 Tg4510 mice, 1 control) were treated
with doxycycline (200 ppm in chow; Harlan Tekland, Madison, WI) to
suppress tau transgene expression for 2 weeks before surgery.
In vivo imaging was performed using a Bio-Rad (Hercules, CA)
1024ES multiphoton microscope (Bio-Rad) with 800 nm excitation (Ti:
Sapphire laser; Maitai, Spectra-Physics, Fremont, CA) as described pre-
viously (Spires et al., 2005). Z-stacks of images were collected in 0.5–5
m steps with resolutions ranging from 0.1 m/pixel to 0.4 m/pixel.
Animalswere killedwith an overdose of aver-
tin (400 mg/kg) and the brain stored in 4%
paraformaldehyde containing 15% glycerol.
Quantitative PCR. To assess caspase 3, 7, 8,
and 9mRNA levels, quantitative, real-time PCR
(qPCR) was performed as described previously
(Matsui et al., 2006). Primer sequences are
shown in supplemental Table 1 (available at
www.jneurosci.org as supplemental material).
Transcripts of interest were quantified using a
modification of the CT method (Fink et al.,
1998).
Immunostaining. Immunostaining of tau
cleaved at Asp 421/422 [TauC3 antibody de-
scribed by Gamblin et al. (2003)] was per-
formed on 50 m floating (primary antibody,
1:100; Biosource, Camarillo, CA; secondary
anti-mouse Alexa-568, 1:200; Invitrogen).
Statistics. Pearson’s correlations and Fisher’s
r to z ( p values) comparing caspase eight levels
and neuron number (Spires et al., 2006) were
calculated using StatView (SAS Institute, Cary,
NC). To compare transgenic to control levels of
caspase eight normalized to glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) levels,
Mann–Whitney U tests were used (caspase
mRNA data were not normally distributed).
Caspase 8 levels normalized to GAPDH at each
age were compared with average control levels,
which do not change with age.
Results
Neurofibrillary pathology is associated
with caspase activation in vivo
We used the rTg4510 mouse model (San-
taCruz et al., 2005), which reversibly expresses P301L mutant
human tau, to investigate neurofibrillary pathology and neuro-
degeneration in vivo. Thioflavin S (ThioS), a standard histologi-
cal dye that is fluorescent only when bound to  pleated sheet
structures, was topically applied to the cortical surface. ThioS
labels neurofibrillary pathology in the living mouse brain at
0.025% concentration in PBS (Fig. 1). In control animals, no
ThioS-positive neurons were observed.
rTg4510mice undergo substantial neuronal loss in the cortex,
50% loss by 8.5 months of age, assessed previously using stereo-
logical counting methods in fixed sections (Spires et al., 2006).
Using these stereological data, we estimate that 1000 neurons
should die each day in the cortical volume of 3.9  109 m3
monitored during in vivo imaging. To investigate cell death pro-
cesses in vivo, we labeled activated caspases with a red fluorescent
indicator of polycaspase activation. In rTg4510 cortex, this indi-
cator labeled occasional neurons’ soma, nuclei, and proximal
dendrites, whereas in other neurons, only the nuclei were labeled
(Fig. 2). In rTg4510 cortex, both neurons with and without
ThioS-positive inclusions had activated caspases; however, the
vast majority of caspase positive neurons contained NFTs. Six
percent of observed tangle-containing cells are caspase positive
and an estimated 0.1% of tangle-free neurons are caspase posi-
tive. This is a 65-fold difference, indicating that cells with NFTs
are much more likely to be caspase positive than those without.
We also used two other indicators of activated caspases that
aremore specific than the polycaspase indicator described above.
One of these recognizes only activated caspase 8 (an “initiator”
caspase) and the other activated caspases 3 and 7 (downstream
“executioner” caspases). We observed both caspase 3 plus 7 (n
2 animals) and caspase 8 activation (n 2 animals, Fig. 2).When
Figure 1. ThioS labels neurofibrillary tangles in vivo. Topical application of 0.025% ThioS to the cortex of rTg4510 mice was
used to observe neurofibrillary tangles.a,b, Low-magnificationmicrographs show that NFTs are prevalent throughout the cortex
of 6-month-old (a) and 9-month-old (b) mice. c– e, At high resolution, most of these lesions appear blue-green and fibrillar
although occasionally less fibrillar lesions are observed which are more blue in color (arrow). ThioS positive neurons were not
observed in control animals (data not shown). Scale bars: a, b, 20m; c– e, 10m.
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used together, the caspase 8 indicator and poly-caspase indicator
colocalized as expected, predominantly in cells with NFTs (data
not shown). Thus both activator and downstream executioner
caspases cascades are activated in a subset of cortical neurons in
the rTg4510 brain.
We considered the possibility that the caspase indicator has
some nonspecific or background activation that leads to false
positive results. However, caspase-positive neurons were never
observed in control animals. As an additional control, two ani-
mals were treated with topical z-vad-fmk (50 M), a pan-caspase
inhibitor. Pretreatment with caspase inhibitor prevented detec-
tion of caspase activation although ThioS positive cells were still
visible. After washing out the inhibitor and reapplying caspase
indicator, caspase activation appeared in the appropriate propor-
tion of NFT-bearing neurons (Fig. 2).
Based on the in vivo evidence of caspase activation, we sought
additional data on the relationship of tau overexpression, NFTs,
and caspase activation. Immunostaining for a tau epitope that
occurs after caspase cleavage at Asp421/422 revealed positive cell
bodies and neuronal processes in the hippocampus and cortex of
rTg4510 mice, but not in nontransgenic animals (Fig. 3). Both
dendrites and axons were clearly labeled in the CA1 region of the
hippocampus. Cortical neurons were only rarely positive for
caspase-cleaved tau, in agreement with the rarity of caspase pos-
itive cells observed in vivo. Tau can be cleaved at Asp421/422 by
caspases 3, 7, and 8 (Gamblin et al., 2003).
We also evaluated molecular methods of assessing caspase
involvement. Previously, we noted that the mRNA for caspases 7
and 8 (but not 3 and 9) were elevated in AD brain (Matsui et al.,
2006). We therefore performed qPCR on mRNA extracted from
rTg4510 animals at 2.5, 4, 5.5, 7, and 8.5 months (Fig. 3). These
results showed elevated caspase 8 mRNA levels at 5.5 and 8.5
months, indicating that the expression of this initiator caspase is
upregulated in these mice as well as being activated as shown by
the cleaved tau immunostaining and in vivo indicator
experiments.
Figure2. Caspase activationoccurs in rTg4510 cortex.a,b,e–h, An indicator of polycaspase
activationapplied in vivo (red) shows that activated caspases arepresentboth in cellswithThioS
positive tangles (green-blue; arrows) and without (arrowheads). Rarely, cells with active
caspases exhibit nuclear fragmentation (asterisks), a morphological characteristic of apoptotic
neurons. c,d, Indicators specific to caspase 3 and7 activation (red; c) and to caspase 8 (green;d)
label neurons showing that both initiator and executioner caspases are active in these mice. e,
Pretreatmentwith the pan-caspase inhibitor z-vad-fmk prevented caspase activation although
ThioS positive cells are still visible. f, After washing out the inhibitor, caspase activation reap-
pears, usually in tangle-bearing cells as expected.g,h, Transgene suppression for 2weeks does
not prevent caspase activation. Scale bar, 10m.
Figure 3. Histological and molecular evidence of caspase upregulation. a, Immunostaining
for tau cleaved at Aps 421/422 revealed cell bodies (arrows) and processes (arrowheads) in the
hippocampus and cortex of rTg4510 tau transgenicmice.b, This activationpersisted after trans-
gene suppression with doxycycline (dox). c, No staining was observed in nontransgenic control
mice. d, Caspase 8mRNA levels (normalized to GAPDH) are elevated in rTg4510mice at 5.5 and
8.5 months compared with control levels (dotted line). Transgene suppression does not signif-
icantly alter caspase levels. *p 0.05, Mann–Whitney U test. Scale bar, 20m.
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Caspase activation does not lead to classical apoptotic death
of neurons
These data suggest that caspase activation can be detected in a
small number of individual neurons in the cortex, and those are
most likely to contain NFTs. Together with our previous obser-
vations that having NFTs was not sufficient, in most neurons, to
cause neuronal death (Spires et al., 2006), this result was surpris-
ing. Moreover, caspase positive neuronal nuclei appeared mor-
phologically identical to their caspase negative neighbors (only
two fragmented nuclei of hundreds observed). If apoptosis were
occurring, wewould expect rapid degeneration of neurons aswell
as fragmenting nuclei, so we imaged some neurons with NFTs
and caspase activation hourly for 4 h (a total of five image time
points). Neurons containing NFTs remained unchanged over
these imaging sessions, even if they were caspase positive (Fig. 4).
Suppression of the tau transgene for 6 weeks in this model
halts ongoing neuronal death without affectingNFTs (SantaCruz
et al., 2005; Spires et al., 2006). We suppressed the tau transgene
for 2 weeks by treatment with oral doxycycline. As expected,
NFTs persisted for the 2 week interval. Surprisingly, however,
caspase activation also remained as prevalent as without trans-
gene suppression (Figs. 2, 4, supplemental Table 2, available at
www.jneurosci.org as supplemental material).
Histological and molecular experiments also support the dis-
sociation of caspase activation and neuronal death. Transgene
suppression for 2 weeks did not remove caspase-cleaved tau from
neurons, nor did 6 weeks of suppression change the levels of
caspase 8 mRNA (Fig. 3). Tissue from the same animals used for
qPCR experiments was previously used to estimate neuron and
tangle numbers in various brain regions (Spires et al., 2006).
Comparing neuronal counts from one hemisphere with the
qPCR results from the contralateral hemisphere showed that
caspase 8 levels are inversely correlated with neuron number.
This indicates an association of caspase 8 upregulation with neu-
ronal loss (correlation,0.611; p 0.002). However, the lack of
change in caspase 8 levels or caspase cleaved tau, and the presence
of activated caspases in vivo after transgene suppression argues
that caspase production and activation are not sufficient to sup-
port ongoing neuronal death, which is halted over the same time
period of suppression.
We further investigated whether neurons in rTg4510 cortex
die via classical caspase-associated apoptosis using histological
markers. Neurons in rTg4510 mice and control nontransgenic
animalswere negative for cleavedPARP [poly(ADP-ribose) poly-
merase], terminal deoxynucleotidyl transferase-mediated
biotinylated UTP nick end labeling (TUNEL), and cleaved
caspase-3 immunostaining (supplemental Fig. 1, available at
www.jneurosci.org as supplemental material), indicating there is
not apoptosis occurring at least as could be detected with these
three markers. Additionally, nuclei of the neurons appeared nor-
mal in histological sections [thousands of cresyl violet stained
nuclei were examined in a previous stereological study (Spires et
al., 2006)]. Furthermore, Western blots probing for fodrin did
not show an increase in caspase cleaved fodrin in rTg4510 brain
above the low background level seen in control animals (data not
shown). Nor was there any evidence of re-entry into the cell cycle
or autophagy as assessed by PCNA (proliferating cell nuclear
antigen), cdk4, or LAMP2 (lysome-associated membrane
protein-2) immunostaining (data not shown). The detection of
activated caspases (8 and 3 plus 7) in vivo, but the absence of
cleaved caspase 3-positive neurons detected in histological sec-
tions may indicate that the in vivo indicator detects low levels of
Figure 4. Caspase activation does not lead to rapid degeneration and persists after transgene suppression. a, In untreated rTg4510 animals, caspase positive cell bodies (red) and cells with NFTs
(blue-green) remain stable over the course of hours of imaging.b, c, Caspase positive cells remain even after transgene suppression and these cell bodies similarly do not degenerate over the course
of hours. The black arrowhead indicates a cell with activated caspases but no tangle, white arrowheads show cells with both NFTs and activated caspases, and the black arrow shows a cell with NFTs
but no active caspases. Scale bar, 10m.
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caspase activation (sufficient to generate caspase-cleaved tau in
neurons), and that these tangle-bearing neurons mount an effec-
tive antiapoptotic strategy that prevents progression to neuronal
death.
Discussion
To investigate the role of neurofibrillary tangles in tau-associated
neuronal death, we have developed amethod, usingmultiphoton
microscopy, to directly observe neurofibrillary lesions and
caspase activation in vivo. This is the first time that NFTs or
caspase activation has been observed in the living brain. These
novel techniques demonstrate an unexpected set of relationships:
caspase activation can be detected in a small subset of neurons,
the vast majority of which contain tangles, but surprisingly, this
activation is not a harbinger of inevitable neuronal death. Neu-
rons that are caspase positive remain so, morphologically nor-
mal, for up to 4 h of continuous imaging. Even more strikingly,
neurons that contain NFTs remain caspase positive 2 weeks after
transgene suppression, which is unexpected because suppression
for 6 weeks prevents additional neuronal loss. The absence of
TUNEL staining and other evidence of apoptotic sequelae also
argue against classical apoptosis as the mechanism of neuronal
death in this model. Our results are surprising because whereas
activation of initiator caspases has been reported as a chronic
event preceding neuronal death in a model of familial amyotro-
phic lateral sclerosis (Pasinelli et al., 2000), executioner caspase
activation is viewed as a direct and inevitable path toward apo-
ptotic cell death that occurs within hours (Chang et al., 2002;
Young et al., 2005). Our results indicate that initiator and execu-
tioner caspases appear to be activated in tangle-bearing neurons,
but longitudinal in vivo imaging uncovers a dissociation between
caspase activation and acute neuronal death.
These data address the important and debated issue of
whether apoptosis is themechanismof neuronal death in tauopa-
thies. Evidence for apoptosis in tauopathies is controversial.
Studies in human AD tissue indicate that caspases are upregu-
lated and activated caspases and their cleavage products are asso-
ciated with NFTs (Rohn et al., 2001; Gamblin et al., 2003; Matsui
et al., 2006), leading to the hypothesis that tangles contribute to
apoptotic neuronal death by activating caspases. However, these
experiments from postmortem tissue do not allow direct confir-
mation that neurons with activated caspases actually undergo
apoptosis. In several othermousemodels of tauopathy, apoptosis
was not found to be amajor contributor to neuronal death (Allen
et al., 2002; Zehr et al., 2004; Andorfer et al., 2005).Our data show
that caspases are activated and associated with NFTs, but caspase
activation is not sufficient to cause acute neuronal degeneration
arguing against apoptosis as the primary mechanism for cell
death in this model.
We propose that tangle-bearing neurons mount an antiapop-
totic strategy that delays neuronal death despite caspase activa-
tion. The antiapoptotic activity could consist of sequestering ac-
tive caspases into cell compartments where they are not
damaging or upregulation of proteins that inhibit apoptosis
(Cotman et al., 2005). The absence of cleaved caspase immuno-
staining in our model may reflect a low level of activity that is
detectable by the in vivo indicator, and sufficient to cause tau
cleavage. The latter cleavage product would be expected to accu-
mulate in NFTs, which may allow for its detection; it is possible
that caspase cleaved tau even contributes to NFT formation or
stabilization (Gamblin et al. 2003). In cell culture and animal
models, tau phosphorylation can protect cells from apoptosis (Li
et al., 2007). The delayed (nonapoptotic) neuronal death in the
rTg4510model may be similar to that observed in cultured neu-
ronswhen delayed caspase-independent death is observed in cells
treated with an apoptosis-inducing agent while caspases are in-
hibited (Lang-Rollin et al., 2003).
In vivo imaging of NFTs allows us to also address the relation-
ship betweenNFTs and neurodegeneration in tauopathies. There
are compelling data supporting the toxicity of aggregated tau in
vitro (Khlistunova et al., 2006); however, data from cell models of
Huntington- and Parkinson-related inclusions (Saudou et al.,
1998; Bodner et al., 2006), and from the observation that expres-
sion of mutant tau in human tauopathies (Reed et al., 2001) and
in Drosophila (Wittmann et al., 2001) can lead to neuronal loss
without passing through a tangle stage raise the possibility that
protein inclusions may be unnecessary for neuronal death or
even be protective. Our previous work on tissue from rTg4510
mice showed that substantial neuronal loss occurs in dentate gy-
rus, which develops very few NFTs, and conversely that there is
no cell loss in striatum despite robust amounts of tangle forma-
tion, raising the possibility thatNFTs are not required and are not
sufficient for cell death in thismodel (Spires et al., 2006).We now
show that NFTs are associated with at least low levels of caspase
activation, and thus are likely associated with neurotoxicity.
However, NFT-bearing cells apparently can mount an anti-
apoptotic strategy that slows down or abrogates apoptosis (Cot-
man et al., 2005), even in the presence of executioner caspases
because activation can occur without obligatory acute neuronal
death. Thus, although NFTs may be associated with toxic phe-
nomenon, they do not appear to be coupled with acute neurode-
generation in this tauopathy model.
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